Zero Ischemia Laparoscopic Partial Nephrectomy (ZILPAREMZ)
Primary Purpose
Small Renal Mass
Status
Withdrawn
Phase
Phase 2
Locations
Canada
Study Type
Interventional
Intervention
Renal Artery Embolization
Partial Nephrectomy (Surgical Resection)
Sponsored by

About this trial
This is an interventional treatment trial for Small Renal Mass
Eligibility Criteria
Inclusion Criteria:
- T1a renal cell carcinomas diagnosed by ultrasonography (US), computed tomography (CT) or fine needle aspiration
- tumor size <4cm in diameter
- predominant exophytic growth
- intraparenchymal depth no greater than 1.5cm, with a minimum distance of 5mm from the urinary collecting system
Exclusion Criteria:
- predominant endophytic nature (depth </= 1.5 cm)
- nearness (<0.5cm) of the tumor to the urinary collecting system
- multiple ipsilateral lesions
- pregnancy
- allergy to intravenous contrast dye
- absolute contraindications to surgical intervention
Sites / Locations
- St. Joseph's Healthcare Hamilton - McMaster Institute of Urology
Arms of the Study
Arm 1
Arm Type
No Intervention
Arm Label
Small Renal Mass
Arm Description
Patient's with a small renal mass will be undergoing embolization prior to laparoscopic partial nephrectomy.
Outcomes
Primary Outcome Measures
Extirpative time
From initial renal tissue breach until completion of bolster placement. Calculated in minutes.
Warm ischemia time
From renal vessel clamping to unclamping during nephrectomy (only if clamping has occurred). Calculated in minutes.
Mean estimated blood loss (measured in ml)
From the start of procedure (Nephrectomy), until the end of the procedure.
Secondary Outcome Measures
Mean hospital stay
Date admitted for procedure until date of discharge. Measure in calendar days.
Blood transfusions
Prior to Embolization procedure and pre and post-nephrectomy.
Conversion to other type of surgery (i.e. Radical Nephrectomy)
Minutes from the start of procedure (Nephrectomy).
Identification of other complications (i.e. readmission, arteriovenous malformations)
Complications will be monitored after patient is discharged up until two years post-operatively.
Overall survival rates
Follow-up will be monitored.
Pathological Results (% of negative margins and benign versus malignant tumours).
Pathology results are usually not released until 7-14 days post nephrectomy.
Full Information
NCT ID
NCT02634385
First Posted
October 10, 2014
Last Updated
July 26, 2016
Sponsor
St. Joseph's Healthcare Hamilton
1. Study Identification
Unique Protocol Identification Number
NCT02634385
Brief Title
Zero Ischemia Laparoscopic Partial Nephrectomy
Acronym
ZILPAREMZ
Official Title
Zero Ischemia Laparoscopic Partial Nephrectomy in Combination With Superselective Renal Artery Embolization for Small Renal Masses: A Feasibility Trial
Study Type
Interventional
2. Study Status
Record Verification Date
July 2016
Overall Recruitment Status
Withdrawn
Why Stopped
No funding to start project.
Study Start Date
November 2015 (undefined)
Primary Completion Date
April 2016 (Anticipated)
Study Completion Date
June 2016 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
St. Joseph's Healthcare Hamilton
4. Oversight
5. Study Description
Brief Summary
Laparoscopic partial nephrectomy (LPN) is often reserved for patients with a small peripheral tumour, in the hands of an experienced surgeon since it demands a high degree of endoscopic skill. Renal vessel clamp for vascular control is a required step during standard LPN. However, this creates a time limiting step for the surgeon and induces renal injury via warm ischemia and reperfusion injury. This novel approach can substantially reduce renal injury during LPN via superselective embolization of level II renal arteries pre-operatively. This technique facilitates the performance of a clamp-less, zero-ischemia LPN, significantly simplifying the procedure by remove time thresholds within which to perform tumor excision. The preliminary results are promising; however, there is a need for further corroboration of their results, in addition to a randomized controlled trial comparing this modified, zero ischemia technique with standard LPN.
Detailed Description
The potential utility of a zero ischemia, laparoscopic, partial nephrectomy portends significant implications for both the surgeon and patient. Firstly, the technical difficulty of a partial nephrectomy will be reduced to a more achievable level owing mainly to the removal of a time limit on surgical resection. With the blood flow halted to downstream tissue containing the renal neoplasm from preoperative embolization, resection can be made to the tumor without clamping of the main renal arteries. This minimizes the ischemic time to non-neoplastic renal tissue, allowing for a renal protective effect. Without the need for clamping, the overall surgical operative time is drastically reduced. With excision made at the ischemic tissue, intra-operative bleeding and ease can be achieved. More surgeons can ultimately attempt at LPN by removing the single most limiting surgical factor, warm ischemic time.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Small Renal Mass
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Small Renal Mass
Arm Type
No Intervention
Arm Description
Patient's with a small renal mass will be undergoing embolization prior to laparoscopic partial nephrectomy.
Intervention Type
Procedure
Intervention Name(s)
Renal Artery Embolization
Intervention Description
Patients will be receiving embolization prior to planned partial nephrectomy.
Intervention Type
Procedure
Intervention Name(s)
Partial Nephrectomy (Surgical Resection)
Intervention Description
Patients will be undergoing planned partial nephrectomy post embolization.
Primary Outcome Measure Information:
Title
Extirpative time
Description
From initial renal tissue breach until completion of bolster placement. Calculated in minutes.
Time Frame
Duration of Surgical Procedure
Title
Warm ischemia time
Description
From renal vessel clamping to unclamping during nephrectomy (only if clamping has occurred). Calculated in minutes.
Time Frame
Duration of Surgical Procedure
Title
Mean estimated blood loss (measured in ml)
Description
From the start of procedure (Nephrectomy), until the end of the procedure.
Time Frame
Duration of Surgical Procedure
Secondary Outcome Measure Information:
Title
Mean hospital stay
Description
Date admitted for procedure until date of discharge. Measure in calendar days.
Time Frame
2-10 Days
Title
Blood transfusions
Description
Prior to Embolization procedure and pre and post-nephrectomy.
Time Frame
From date of pre-op up to 6 months post-op
Title
Conversion to other type of surgery (i.e. Radical Nephrectomy)
Description
Minutes from the start of procedure (Nephrectomy).
Time Frame
Duration of Surgical Procedure
Title
Identification of other complications (i.e. readmission, arteriovenous malformations)
Description
Complications will be monitored after patient is discharged up until two years post-operatively.
Time Frame
Up to 24 months post-operatively.
Title
Overall survival rates
Description
Follow-up will be monitored.
Time Frame
Up to 24 months post-operatively.
Title
Pathological Results (% of negative margins and benign versus malignant tumours).
Description
Pathology results are usually not released until 7-14 days post nephrectomy.
Time Frame
7 to 14 days post nephrectomy.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
T1a renal cell carcinomas diagnosed by ultrasonography (US), computed tomography (CT) or fine needle aspiration
tumor size <4cm in diameter
predominant exophytic growth
intraparenchymal depth no greater than 1.5cm, with a minimum distance of 5mm from the urinary collecting system
Exclusion Criteria:
predominant endophytic nature (depth </= 1.5 cm)
nearness (<0.5cm) of the tumor to the urinary collecting system
multiple ipsilateral lesions
pregnancy
allergy to intravenous contrast dye
absolute contraindications to surgical intervention
Facility Information:
Facility Name
St. Joseph's Healthcare Hamilton - McMaster Institute of Urology
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8N4A6
Country
Canada
12. IPD Sharing Statement
Learn more about this trial
Zero Ischemia Laparoscopic Partial Nephrectomy
We'll reach out to this number within 24 hrs